Document is current
Any future updates will be listed below
-
Authors
Kim, G W
Lin, J E
Snook, A E
Aing, A S
Merlino, D J
Li, P
Waldman, S A
- License Information
-
More Information
Article History
Received: 11 January 2016
Revised: 16 March 2016
Accepted: 7 April 2016
First Online: 23 May 2016
Competing interests
: SAW is the chair of the Data Safety Monitoring Board for the CHART-1 trial sponsored by Cardio3 Biosciences, a member of the Scientific Advisory Board for Immunovative Therapies, and the chair (uncompensated) of the Scientific Advisory Board of Targeted Diagnostics & Therapeutics, Inc. that provided research funding that, in part, supported this work and has a license to commercialize inventions related to this work.
